Artelo Biosciences ARTL
NASDAQ ARTL
$4.07 -0.23 (-5.35%)
At close: Sep 29, 2026 · 4:00 PM EDT

Artelo Biosciences (ARTL) Non-Current Debt (2017 - 2021)

Updated

Artelo Biosciences (ARTL) reported Non-Current Debt of $338.00 for Q4 2021, compared with -$1,960 a year earlier.

Analysis

Artelo Biosciences (ARTL) Non-Current Debt (2017 - 2021) Analysis & Trends

For FY2021, Artelo Biosciences posted Non-Current Debt of -$8,000.

  • By year, Non-Current Debt came in at -$5,000 in FY2020, -$17,228 in FY2019, -$18,056 in FY2018 and -$11,317 in FY2017.
  • The Q4 2021 figure ranks as the highest quarterly Non-Current Debt in data going back to Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Artelo Biosciences 85,673.20 -5.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2021 338.00
Feb 28, 2021 -7,338.00
Nov 30, 2020 -1,000.00
Aug 31, 2020 -1,960.00
Nov 30, 2019 -3,040.00
Aug 31, 2019 -9,141.00
May 31, 2019 -2,866.00
Feb 28, 2019 -4,663.00
Nov 30, 2018 -558.00
Aug 31, 2018 -1,454.00
May 31, 2018 -759.00
Feb 28, 2018 -7,338.00
Nov 30, 2017 -8,505.00
API Access

Artelo Biosciences Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ARTL&period=max&api_key=YOUR_API_KEY